Gut bacteria supplement studied for arthritis relief

NCT ID NCT05718583

First seen Nov 01, 2025 · Last updated May 02, 2026 · Updated 30 times

Summary

This small pilot study tested whether a short-chain fatty acid (SCFA) supplement could change gut bacteria and immune responses in people with rheumatoid arthritis who did not get enough help from methotrexate. About 20 participants took the supplement for one month, with an optional second month. Researchers collected stool, urine, and blood samples to measure changes in gut microbiome and immune cells. The goal was to gather early data, not to prove a treatment effect.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • NYU Langone Health Orthopedic Center

    New York, New York, 10016, United States

Conditions

Explore the condition pages connected to this study.